Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk (EPICODE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02193464|
Recruitment Status : Recruiting
First Posted : July 17, 2014
Last Update Posted : July 26, 2016
|Condition or disease|
|Idiopathic Chronic Inflammatory Bowel Disease|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||100 participants|
|Target Follow-Up Duration:||10 Years|
|Official Title:||Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea|
|Study Start Date :||September 2014|
|Estimated Primary Completion Date :||September 2017|
|Estimated Study Completion Date :||December 2017|
|inflammatory bowel disease|
- All newly diagnosed cases [ Time Frame: one year ]In one year, all inflammatory bowel disease including Crohn's disease and ulcerative colitis which is newly diagnosed in Daegu-Gyeongbuk province of Korea is recorded.
- All operation cases [ Time Frame: one year ]For one year, all patients who have surgical managements for IBD are counted.
- All cases of disease relapse [ Time Frame: one year ]For one year, all patients who have disease worsening are counted.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02193464
|Contact: Eun Soo Kim, MD. PhDfirstname.lastname@example.org|
|Korea, Republic of|
|Keimyung University Dongsan Medical Center||Recruiting|
|Daegu, Korea, Republic of, 700-712|
|Contact: Eun Soo Kim, MD, PhD email@example.com|
|Principal Investigator: Eun Soo Kim, MD, PhD|
|Principal Investigator:||Eun Soo Kim, MD, PhD||Keimyung University School of Medicine|